Zobrazeno 1 - 6
of 6
pro vyhledávání: '"L. Nørgård Petersen"'
Autor:
H. Blons, J. F. Emile, K. Le Malicot, C. Julié, A. Zaanan, J. Tabernero, E. Mini, G. Folprecht, J. L. Van Laethem, J. Thaler, J. Bridgewater, L. Nørgård Petersen, E. Van Cutsem, C. Lepage, M. A. Zawadi, R. Salazar, P. Laurent Puig, J. Taieb, PETACC8 investigators: […, Andrea Martoni, BIASCO, GUIDO
Publikováno v:
Annals of Oncology. 25:2378-2385
BACKGROUND: The prognostic value of KRAS mutations in colon adenocarcinoma is controversial. We examined this question as an ancillary study of the PETACC8 phase III trial.PATIENTS AND METHODS: We analyzed the prognostic impact of KRAS exon 2 mutatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27095b7aab4a25681eb8dc88bc483247
https://doi.org/10.1093/annonc/mdu464
https://doi.org/10.1093/annonc/mdu464
Autor:
C.-B. Levaché, J. Tabernero, Julien Taieb, J.-L. Van Laethem, Géraldine Perkins, L. Saban-Roche, K. Le Malicot, J.F. Emile, Gunnar Folprecht, L. Nørgård Petersen, J. Thaler, John Bridgewater, Enrico Mini, Eduardo Sánchez, Côme Lepage, Aziz Zaanan, R. Balogoum, S. Fratte, Claire Mulot, Pierre Laurent-Puig
Publikováno v:
Annals of oncology
41st ESMO Congress (ESMO 2016)
41st ESMO Congress (ESMO 2016), Oct 2016, Copenhague, Denmark. pp.4610, ⟨10.1093/annonc/mdw370.10⟩
41st ESMO Congress (ESMO 2016), Oct 2016, Copenhague, Denmark. Annals of oncology, 27 (suppl_6), pp.4610, 2016, Abstract Book of the 41st ESMO Congress (ESMO 2016), 7-11 October 2016, Copenhagen, Denmark. 〈https://academic.oup.com/annonc/article-abstract/27/suppl_6/461O/2799200/Adjuvant-FOLFOX-cetuximab-vs-FOLFOX-in-full-RAS?redirectedFrom=fulltext〉. 〈10.1093/annonc/mdw370.10〉
41st ESMO Congress (ESMO 2016)
41st ESMO Congress (ESMO 2016), Oct 2016, Copenhague, Denmark. pp.4610, ⟨10.1093/annonc/mdw370.10⟩
41st ESMO Congress (ESMO 2016), Oct 2016, Copenhague, Denmark. Annals of oncology, 27 (suppl_6), pp.4610, 2016, Abstract Book of the 41st ESMO Congress (ESMO 2016), 7-11 October 2016, Copenhagen, Denmark. 〈https://academic.oup.com/annonc/article-abstract/27/suppl_6/461O/2799200/Adjuvant-FOLFOX-cetuximab-vs-FOLFOX-in-full-RAS?redirectedFrom=fulltext〉. 〈10.1093/annonc/mdw370.10〉
IF 9.269; International audience; Background: RAS mutations have been shown to confer resistance to anti-EGFR treatment. We assessed here the results of the PETACC8 trial (Cetuximab + FOLFOX vs FOLFOX) in full wild type (WT) patients (pts) (RAS & BRA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::952387ffb860ac94b0e2dc4132bf66c9
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01494512
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01494512
Autor:
T. Bocker Edmonston, C. Schmutte, L.J. Rasmussen, T. Thykjaer, L. Nørgård Petersen, Torben F. Ørntoft, Mogens Spang-Thomsen, Richard Fishel, P. Keller, Lasse Tengbjerg Hansen
Publikováno v:
European Journal of Cancer. 39:1456-1467
The role of mismatch repair (MMR) in small-cell lung cancer (SCLC) is controversial, as the phenotype of a MMR-deficiency, microsatellite instability (MSI), has been reported to range from 0 to 76%. We studied the MMR pathway in a panel of 21 SCLC ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9254e0bad2184ed632a3f3c08fac2da3
https://doi.org/10.1016/s0959-8049(03)00306-x
https://doi.org/10.1016/s0959-8049(03)00306-x
Autor:
Julien Taieb, L. Nørgård Petersen, Anne Cayre, J-F. Ramé, J. Tabernero, Christophe Locher, K. Le Malicot, G. Folprecht, John Bridgewater, Ralyath Balogoun, J. Thaler, Frédérique Penault-Llorca, J-L. van Laethem, Pierre Laurent-Puig, C. Lagorce, S. Ellis, Côme Lepage, Enrico Mini, Eduardo Sánchez
Publikováno v:
Annals of Oncology. 27:vi151
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc66dbc0fcd3e8a62c65b0e6aacb455c
https://doi.org/10.1093/annonc/mdw370.08
https://doi.org/10.1093/annonc/mdw370.08
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.